Selaginellin Inhibits Melanogenesis via the MAPK Signaling Pathway
Ying Zhou,Hong-Liang Zeng,Xin-Yue Wen,Ling Jiang,Chu-Han Fu,Yi-Bo Hu,Xin-Xin Lei,Li Zhang,Xing Yu,Si-Yu Yang,Li-Hua Huang,Hong Xiang,Jin-Hua Huang,Jing Chen,Li Lei,Qing-Hai Zeng
DOI: https://doi.org/10.1021/acs.jnatprod.1c00971
IF: 5.1
2022-03-15
Journal of Natural Products
Abstract:Hyperpigmented skin diseases such as melasma, freckles, and melanosis usually mar the appearance of patients. Traditional herbal medicines are highly accepted in inhibiting skin pigmentation, with advantages of high efficiency, low cost, and low side effects. Selaginellin (SEL), one of the active compounds of selaginella, has been proved to be exhibit antineoplastic, antioxidant, antisenescence, and antiapoptosis activities. In this study, we found that SEL can inhibit melanogenesis in vitro and in vivo. A mechanism study found that SEL inhibits melanogenesis through inhibiting the mitogen-activated protein kinase (MAPK) signaling pathway, then down-regulating the expression of microphthalmia-associated transcription factor (MITF) and downstream genes tyrosinase (TYR) and tyrosinase-related protein 2 (TYRP2). UVB-activated paracrine function of fibroblasts and keratinocytes promotes melanogenesis of melanocytes. Interestingly, SEL antagonizes UVB-activated paracrine function of fibroblasts and keratinocytes. These findings indicate that SEL can be a potential whitening compound to inhibit melanogenesis.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jnatprod.1c00971.Primer sequences, the cytotoxicity of SEL, the results of melanin staining, TYR fluorescence, Western blotting, and qRT-PCR after different treatments (PDF)This article has not yet been cited by other publications.
plant sciences,chemistry, medicinal,pharmacology & pharmacy